Ülgen Ege, Karacan Sıla, Gerlevik Umut, Can Özge, Bilguvar Kaya, Oktay Yavuz, B Akyerli Cemaliye, K Yüksel Şirin, E Danyeli Ayça, Tihan Tarık, Sezerman O Uğur, Yakıcıer M Cengiz, Pamir M Necmettin, Özduman Koray
Department of Biostatistics and Medical Informatics, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Turkey.
Department of Medical Engineering, Faculty of Engineering, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Turkey.
Biomedicines. 2020 Dec 7;8(12):574. doi: 10.3390/biomedicines8120574.
Little is known about the mutational processes that shape the genetic landscape of gliomas. Numerous mutational processes leave marks on the genome in the form of mutations, copy number alterations, rearrangements or their combinations. To explore gliomagenesis, we hypothesized that gliomas with different underlying oncogenic mechanisms would have differences in the burden of various forms of these genomic alterations. This was an analysis on adult diffuse gliomas, but -mutant gliomas as well as diffuse midline gliomas -K27M were excluded to search for the possible presence of new entities among the very heterogenous group of -WT glioblastomas. The cohort was divided into two molecular subsets: (1) Molecularly-defined GBM (mGBM) as those that carried molecular features of glioblastomas (including promoter mutations, 7/10 pattern, or -amplification), and (2) those who did not (others). Whole exome sequencing was performed for 37 primary tumors and matched blood samples as well as 8 recurrences. Single nucleotide variations (SNV), short insertion or deletions (indels) and copy number alterations (CNA) were quantified using 5 quantitative metrics (SNV burden, indel burden, copy number alteration frequency-wGII, chromosomal arm event ratio-CAER, copy number amplitude) as well as 4 parameters that explored underlying oncogenic mechanisms (chromothripsis, double minutes, microsatellite instability and mutational signatures). Findings were validated in the TCGA pan-glioma cohort. mGBM and "Others" differed significantly in their SNV (only in the TCGA cohort) and CNA metrics but not indel burden. SNV burden increased with increasing age at diagnosis and at recurrences and was driven by mismatch repair deficiency. On the contrary, indel and CNA metrics remained stable over increasing age at diagnosis and with recurrences. Copy number alteration frequency (wGII) correlated significantly with chromothripsis while CAER and CN amplitude correlated significantly with the presence of double minutes, suggesting separate underlying mechanisms for different forms of CNA.
关于塑造胶质瘤基因图谱的突变过程,我们所知甚少。众多突变过程会以突变、拷贝数改变、重排或它们的组合形式在基因组上留下印记。为了探究胶质瘤的发生机制,我们推测具有不同潜在致癌机制的胶质瘤在这些基因组改变的各种形式的负担上会存在差异。这是一项针对成人弥漫性胶质瘤的分析,但排除了IDH突变型胶质瘤以及弥漫性中线胶质瘤(H3K27M),以便在非常异质的IDH野生型胶质母细胞瘤组中寻找可能存在的新实体。该队列被分为两个分子亚组:(1)分子定义的胶质母细胞瘤(mGBM),即那些具有胶质母细胞瘤分子特征的肿瘤(包括TERT启动子突变、7/10模式或EGFR扩增),以及(2)不具有这些特征的肿瘤(其他肿瘤)。对37例原发性肿瘤及匹配的血液样本以及8例复发病例进行了全外显子测序。使用5种定量指标(单核苷酸变异负担、插入缺失负担、拷贝数改变频率-wGII、染色体臂事件比率-CAER、拷贝数幅度)以及4个探索潜在致癌机制的参数(染色体碎裂、双微体、微卫星不稳定性和突变特征)对单核苷酸变异(SNV)、短插入或缺失(indels)和拷贝数改变(CNA)进行了量化。研究结果在TCGA泛胶质瘤队列中得到了验证。mGBM和“其他肿瘤”在SNV(仅在TCGA队列中)和CNA指标上存在显著差异,但在插入缺失负担上没有差异。SNV负担随着诊断年龄和复发年龄的增加而增加,并且由错配修复缺陷驱动。相反,插入缺失和CNA指标在诊断年龄增加和复发时保持稳定。拷贝数改变频率(wGII)与染色体碎裂显著相关,而CAER和CN幅度与双微体的存在显著相关,这表明不同形式的CNA存在不同的潜在机制。